SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-347354
Filing Date
2021-12-03
Accepted
2021-12-03 09:19:29
Documents
7
Period of Report
2021-12-03

Document Format Files

Seq Description Document Type Size
1 6-K d224773d6k.htm 6-K 17352
2 EX-10.1 d224773dex101.htm EX-10.1 191676
3 EX-10.2 d224773dex102.htm EX-10.2 245275
4 EX-99.1 d224773dex991.htm EX-99.1 12065
5 GRAPHIC g224773g00h79.jpg GRAPHIC 12837
6 GRAPHIC g224773g1202210425765.jpg GRAPHIC 4996
7 GRAPHIC g224773g1202210426228.jpg GRAPHIC 2881
  Complete submission text file 0001193125-21-347354.txt   496546
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 211468860
SIC: 2834 Pharmaceutical Preparations